Søgeresultater - V. A. Shevtsov
- Showing 1 - 18 results of 18
-
1
Analysis of Efficacy and Safety of Tick-Borne Encephalitis Vaccines af T. Yu. Kozlova, L. M. Khantimirova, A. V. Rukavishnikov, V. A. Shevtsov
Udgivet 2018-03-01This article provides a review on efficacy and safety of tick-borne encephalitis vaccines licensed in the Russian Federation. It highlights that both Russian and imported tick-borne encephalitis vaccines demonstrate high immunogenicity, safety and epidemiological effectiveness in regions with hig...
Få fuldtekst
Article -
2
THE EPIDEMIOLOGICAL AND IMMUNOLOGICAL EFFECTIVENESS OF VACCINATION OF HEPATITIS A IN ORGANIZED GROUPS OF MILITARY PERSONNEL. IMMUNOLOGICALLY EFFECTIVE DOMESTIC VACCINE «HEP-IN-A-VA... af V. G. Akimkin, S. I. Korotchenko, A. V. Alimov, V. A. Shevtsov
Udgivet 2012-12-01Since 2004 the incidence of hepatitis A of conscripts declined by more than 70 times, which happened primarily due to vaccination. The paper under review presents the characteristics of a phased strategy of specific prevention of hepatitis A, provides the comparative analysis of the immunological an...
Få fuldtekst
Article -
3
Comparative Analysis of Approaches to Assess the Quality of Inactivated Influenza Vaccines: Regulatory Requirements in the Russian Federation and European Union af L. M. Khantimirova, S. G. Guseva, V. A. Shevtsov, V. A. Merkulov, V. P. Bondarev
Udgivet 2021-01-01The experience with the influenza pandemic caused by strain A (H1N1) 2009 and the existing gaps in standardizing and evaluating the quality and effectiveness of vaccines for influenza prevention have led the European Union (EU) to recognize the need to review / update the current guidelines on requi...
Få fuldtekst
Article -
4
Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination af L. M. Khantimirova, T. Yu. Kozlova, E. L. Postnova, V. A. Shevtsov, A. V. Rukavishnikov
Udgivet 2018-12-01The article presents the results of a retrospective analysis of viral hepatitis B incidence in the Russian Federation from 2013 to 2017, taking into account the use of vaccines included into the National Immunisation Schedule and the Immunisation Programme in Case of Epidemic Outbreaks. The analysis...
Få fuldtekst
Article -
5
Promising opportunities to improve polio vaccines af E. E. Evreinova, L. M. Khantimirova, V. A. Shevtsov, V. A. Merkulov, V. P. Bondarev
Udgivet 2022-07-01Polioviruses belong to Enterovirus C species and cause severe lesions of the nervous system. In the post-polio eradication era, the World Health Organisation recommends inactivated polio vaccines for effective long-term protection of the population. In order to meet the needs of global health, it is...
Få fuldtekst
Article -
6
Rotavirus Epidemiology and Vaccination Tactics af V. P. Bondarev, V. A. Shevtsov, I. N. Indikova, E. E. Evreinova, D. V. Gorenkov
Udgivet 2019-06-01Rotavirus infection is a widespread cause of severe gastroenteritis in children in low-income countries. Specific prophylaxis in young children has become the most important means of combating severe rotavirus gastroenteritis. The review presents current data on the molecular biology and genetic div...
Få fuldtekst
Article -
7
Experimental Study of Grippferon Antiviral Activity Against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro af S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, G. V. Borisevich, V. P. Bondarev, V. A. Shevtsov
Udgivet 2020-05-01Analysis of the efficacy of Grippferon vs. the reference drugs Realdiron and Reaferon-EC against the influenza virus A(H1N1)/2009 in susceptible static cell cultures showed that in the concentrations tested it was efficient in inhibition of the virus cytopathic activity and generation of specific he...
Få fuldtekst
Article -
8
Vaccine Safety and Efficacy in Preventing Rotavirus Infection af V. A. Shevtsov, E. E. Evreinova, I. N. Indikova, L. M. Khantimirova, D. V. Gorenkov, A. V. Rukavishnikov
Udgivet 2019-12-01The rotavirus infection causes acute gastroenteritis and is a major cause of lethal severe dehydrating diarrhoea in children under 5 years of age worldwide. Live attenuated rotavirus vaccines are the only means of preventing severe forms of the disease. The aim of the study was to analyse the twenty...
Få fuldtekst
Article -
9
An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare af D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir
Udgivet 2020-03-01Coronaviruses are the largest group of known positive-strand RNA viruses. Coronavirus infection can affect various animal species, as well as humans. Over the past two decades, coronaviruses have caused epidemic outbreaks of two respiratory diseases: the Middle East Respiratory Syndrome and Severe A...
Få fuldtekst
Article -
10
Epidemiology of hepatitis A and vaccination policy af I. N. Indikova, V. A. Shevtsov, A. R. Volgin, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Udgivet 2018-02-01Hepatitis A (HA) is an acute infectious disease of the liver caused by the hepatitis A virus (HAV). HA disease incidence rate is closely linked to the social and economical development. The results of seroepidemiologic studies show that the prevalence of anti-HAV antibodies in population ranges from...
Få fuldtekst
Article -
11
The analysis of a long-term experience of studying inactivated cell-culture vaccines for preventing tick-borne encephalitis of domestic and foreign manufacture in terms of specific... af M. S. Vorobieva, O. S. Afonina, O. A. Barhaleva, M. S. Shcherbinina, K. A. Sarkisyan, A. V. Rukavishnikov, V. A. Shevtsov, V. P. Bondarev
Udgivet 2018-02-01The analysis of the use of the method for the evaluation of specific (immunogenic) activity of vaccines for preventing tick-borne encephalitis (TBE vaccines) against protective dilution (PD50) and the minimum immunizing dose (MID50) has been performed. The method was standardized and submitted to th...
Få fuldtekst
Article -
12
Cell cultures in replacement therapy af E. M. Petruchuk, N. V. Shalunova, Yu. V. Olefir, I. V. Borisevich, V. V. Perekrest, V. A. Shevtsov, A. V. Rukavishnikov, L. M. Khantimirova
Udgivet 2018-02-01Cell replacement therapy is one of the top priority areas of modern medicine, which is aimed at restoring the structure and functions of damaged tissues by transplanting cells grown in vitro . The article summarizes data obtained in several studies of diploid cell lines (allogeneic fibroblasts) used...
Få fuldtekst
Article -
13
The Results of Re-certification of Reference Standard Sample Used for the Examination of Quality Smallpox Vaccines af A. V. Muhacheva, V. V. Perekrest, A. A. Movsesyants, K. A. Sarkisyan, A. U. Butyrskiy, O. V. Fadeikina, R. A. Volkova, D. V. Shvedov, V. A. Shevtsov
Udgivet 2016-12-01The article presents the results of research quality of drugs for the prevention of smallpox during the period from 2007 to 2015 years, where the reference standard uses industry standard of activity, specificity (identification) and necrotic activity of smallpox vaccine, on indicators: «Specific ac...
Få fuldtekst
Article -
14
Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad af V. A. Shevtsov, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, I. N. Indikova, E. E. Evreinova, A. V. Rukavishnikov, L. M. Khantimirova, D. V. Gorenkov
Udgivet 2019-03-01The management of post-approval changes to registration dossiers for medicinal products is one of the most important factors for ensuring sustainable quality, safety and efficacy of medicines. Competent authorities that use the module format of the registration dossier, i.e. the regulatory authoriti...
Få fuldtekst
Article -
15
Analysis of biological and genetic stability of tick-borne encephalitis strain 205 used in the production of tick-borne encephalitis vaccines EnceVir and EnceVir Neo for children af M. S. Vorobyeva, G. M. Ignatyev, N. A. Netesova, E. V. Otrashevskaya, N. Kh. Stavitskaya, M. S. Shcherbinina, K. A. Sarkisyan, V. A. Shevtsov, A. V. Rukavishnikov, V. P. Bondarev
Udgivet 2018-02-01The article presents the results of a long-term study of biological and genetic stability of tick-borne encephalitis strain 205 which is used by the FSUE «SPA «Microgen» to produce tick-borne encephalitis vaccines EnceVir (for adults) and EnceVir Neo for children, both of which are tissue cultured,...
Få fuldtekst
Article -
16
Vaccines with adjuvants. Preclinical studies af Zh. I. Avdeeva, N. A. Alpatova, V. P. Bondarev, R. A. Volkova, N. I. Lonskaya, E. V. Lebedinskaya, N. V. Medunitsyn, A. N. Mironov, N. A. Ozeretskovsky, A. A. Soldatov, V. A. Shevtsov
Udgivet 2018-02-01The paper presents the data on safety and efficacy assessment of adjuvants and vaccines with adjuvants at the stages of development and preclinical studies based on international recommendations. The presence of an adjuvant in vaccine content ensures higher expressing and prolonged specific immunity...
Få fuldtekst
Article -
17
Mycoplasma - contamination of cell cultures af N. V. Shalunova, R. A. Volkova, A. R. Volgin, E. M. Petruchuk, Z. E. Berdnikova, E. V. Elbert, V. A. Shevtsov, A. V. Rukavishnikov, I. S. Semenova, O. V. Merkulova, G. A. Trusov, N. V. Tereshkina, O. A. Rachinskaj, I. N. Indikova, E. V. Lebedinskaya, E. D. Mytsa
Udgivet 2018-02-01The safety of biological products derived from animal cells is associated with the properties of the cells themselves or their components, as well as with the possible presence of contaminants of microbial and viral origin. The suitability of cell substrate for production of prophylactic preparation...
Få fuldtekst
Article -
18
Approaches to Reduce Adverse Effect of Vaccinia Virus in Orally Immunized Mice af D. O. Galakhova, Ar. A. Sergeev, E. V. Shevtsova, Al. A. Sergeev, A. S. Zamedyanskaya, K. A. Titova, L. N. Shishkina, L. E. Bulychev, S. V. Borisevich, V. N. Podkuiko, A. P. Pirozhkov, A. V. Koval’Chuk, Ya. V. Polyansky, E. Yu. Vakhnov, V. V. Perekrest, V. A. Shevtsov, A. P. Agafonov, A. N. Sergeev
Udgivet 2016-03-01Objective of the investigation was to model the adverse action of vaccinia virus (VV), caused by oral immunization of mice and to evaluate efficacy of its reduction, using therapeutic and prophylactic drugs. Materials and methods. Virological and immunological research methods were used. Results and...
Få fuldtekst
Article